IBDEI01F ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1491,1,3,0)
 ;;=3^SP.SCR EXAM, OTH CHLA
 ;;^UTILITY(U,$J,358.3,1491,1,4,0)
 ;;=4^V73.88
 ;;^UTILITY(U,$J,358.3,1491,2)
 ;;=^295832
 ;;^UTILITY(U,$J,358.3,1492,0)
 ;;=V73.89^^21^115^72
 ;;^UTILITY(U,$J,358.3,1492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1492,1,3,0)
 ;;=3^SP SCR EXAM, OTH SP VIR
 ;;^UTILITY(U,$J,358.3,1492,1,4,0)
 ;;=4^V73.89
 ;;^UTILITY(U,$J,358.3,1492,2)
 ;;=^295833
 ;;^UTILITY(U,$J,358.3,1493,0)
 ;;=V74.0^^21^115^55
 ;;^UTILITY(U,$J,358.3,1493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1493,1,3,0)
 ;;=3^SCREENING FOR CHOLERA
 ;;^UTILITY(U,$J,358.3,1493,1,4,0)
 ;;=4^V74.0
 ;;^UTILITY(U,$J,358.3,1493,2)
 ;;=^295633
 ;;^UTILITY(U,$J,358.3,1494,0)
 ;;=V74.1^^21^115^68
 ;;^UTILITY(U,$J,358.3,1494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1494,1,3,0)
 ;;=3^SCREENING-PULMONARY TB
 ;;^UTILITY(U,$J,358.3,1494,1,4,0)
 ;;=4^V74.1
 ;;^UTILITY(U,$J,358.3,1494,2)
 ;;=^108715
 ;;^UTILITY(U,$J,358.3,1495,0)
 ;;=V74.2^^21^115^61
 ;;^UTILITY(U,$J,358.3,1495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1495,1,3,0)
 ;;=3^SCREENING FOR LEPROSY
 ;;^UTILITY(U,$J,358.3,1495,1,4,0)
 ;;=4^V74.2
 ;;^UTILITY(U,$J,358.3,1495,2)
 ;;=^295634
 ;;^UTILITY(U,$J,358.3,1496,0)
 ;;=V74.3^^21^115^57
 ;;^UTILITY(U,$J,358.3,1496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1496,1,3,0)
 ;;=3^SCREENING FOR DIPHTHERIA
 ;;^UTILITY(U,$J,358.3,1496,1,4,0)
 ;;=4^V74.3
 ;;^UTILITY(U,$J,358.3,1496,2)
 ;;=^295635
 ;;^UTILITY(U,$J,358.3,1497,0)
 ;;=V74.4^^21^115^28
 ;;^UTILITY(U,$J,358.3,1497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1497,1,3,0)
 ;;=3^SCREEN-BACT CONJUNCTIVIT
 ;;^UTILITY(U,$J,358.3,1497,1,4,0)
 ;;=4^V74.4
 ;;^UTILITY(U,$J,358.3,1497,2)
 ;;=^295636
 ;;^UTILITY(U,$J,358.3,1498,0)
 ;;=V74.5^^21^115^19
 ;;^UTILITY(U,$J,358.3,1498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1498,1,3,0)
 ;;=3^SCREEN FOR VENERAL DIS
 ;;^UTILITY(U,$J,358.3,1498,1,4,0)
 ;;=4^V74.5
 ;;^UTILITY(U,$J,358.3,1498,2)
 ;;=^295637
 ;;^UTILITY(U,$J,358.3,1499,0)
 ;;=V74.6^^21^115^64
 ;;^UTILITY(U,$J,358.3,1499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1499,1,3,0)
 ;;=3^SCREENING FOR YAWS
 ;;^UTILITY(U,$J,358.3,1499,1,4,0)
 ;;=4^V74.6
 ;;^UTILITY(U,$J,358.3,1499,2)
 ;;=^295638
 ;;^UTILITY(U,$J,358.3,1500,0)
 ;;=V74.8^^21^115^29
 ;;^UTILITY(U,$J,358.3,1500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1500,1,3,0)
 ;;=3^SCREEN-BACTERIAL DIS NEC
 ;;^UTILITY(U,$J,358.3,1500,1,4,0)
 ;;=4^V74.8
 ;;^UTILITY(U,$J,358.3,1500,2)
 ;;=^295639
 ;;^UTILITY(U,$J,358.3,1501,0)
 ;;=V75.0^^21^115^48
 ;;^UTILITY(U,$J,358.3,1501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1501,1,3,0)
 ;;=3^SCREEN-RICKETTSIAL DIS
 ;;^UTILITY(U,$J,358.3,1501,1,4,0)
 ;;=4^V75.0
 ;;^UTILITY(U,$J,358.3,1501,2)
 ;;=^295641
 ;;^UTILITY(U,$J,358.3,1502,0)
 ;;=V75.1^^21^115^62
 ;;^UTILITY(U,$J,358.3,1502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1502,1,3,0)
 ;;=3^SCREENING FOR MALARIA
 ;;^UTILITY(U,$J,358.3,1502,1,4,0)
 ;;=4^V75.1
 ;;^UTILITY(U,$J,358.3,1502,2)
 ;;=^295642
 ;;^UTILITY(U,$J,358.3,1503,0)
 ;;=V75.2^^21^115^15
 ;;^UTILITY(U,$J,358.3,1503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1503,1,3,0)
 ;;=3^SCREEN FOR LEISHMANIASIS
 ;;^UTILITY(U,$J,358.3,1503,1,4,0)
 ;;=4^V75.2
 ;;^UTILITY(U,$J,358.3,1503,2)
 ;;=^295643
 ;;^UTILITY(U,$J,358.3,1504,0)
 ;;=V75.3^^21^115^53
 ;;^UTILITY(U,$J,358.3,1504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1504,1,3,0)
 ;;=3^SCREEN-TRYPANOSOMIASIS
 ;;^UTILITY(U,$J,358.3,1504,1,4,0)
 ;;=4^V75.3
 ;;^UTILITY(U,$J,358.3,1504,2)
 ;;=^295644
 ;;^UTILITY(U,$J,358.3,1505,0)
 ;;=V75.4^^21^115^41
 ;;^UTILITY(U,$J,358.3,1505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1505,1,3,0)
 ;;=3^SCREEN-MYCOTIC INFECT
 ;;^UTILITY(U,$J,358.3,1505,1,4,0)
 ;;=4^V75.4
 ;;^UTILITY(U,$J,358.3,1505,2)
 ;;=^295645
 ;;^UTILITY(U,$J,358.3,1506,0)
 ;;=V75.5^^21^115^49
 ;;^UTILITY(U,$J,358.3,1506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1506,1,3,0)
 ;;=3^SCREEN-SCHISTOSOMIASIS
 ;;^UTILITY(U,$J,358.3,1506,1,4,0)
 ;;=4^V75.5
 ;;^UTILITY(U,$J,358.3,1506,2)
 ;;=^295646
 ;;^UTILITY(U,$J,358.3,1507,0)
 ;;=V75.6^^21^115^10
 ;;^UTILITY(U,$J,358.3,1507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1507,1,3,0)
 ;;=3^SCREEN FOR FILARIASIS
 ;;^UTILITY(U,$J,358.3,1507,1,4,0)
 ;;=4^V75.6
 ;;^UTILITY(U,$J,358.3,1507,2)
 ;;=^295647
 ;;^UTILITY(U,$J,358.3,1508,0)
 ;;=V75.7^^21^115^13
 ;;^UTILITY(U,$J,358.3,1508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1508,1,3,0)
 ;;=3^SCREEN FOR HELMINTHIASIS
 ;;^UTILITY(U,$J,358.3,1508,1,4,0)
 ;;=4^V75.7
 ;;^UTILITY(U,$J,358.3,1508,2)
 ;;=^295648
 ;;^UTILITY(U,$J,358.3,1509,0)
 ;;=V75.8^^21^115^43
 ;;^UTILITY(U,$J,358.3,1509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1509,1,3,0)
 ;;=3^SCREEN-PARASITIC DIS NEC
 ;;^UTILITY(U,$J,358.3,1509,1,4,0)
 ;;=4^V75.8
 ;;^UTILITY(U,$J,358.3,1509,2)
 ;;=^295649
 ;;^UTILITY(U,$J,358.3,1510,0)
 ;;=V76.0^^21^115^24
 ;;^UTILITY(U,$J,358.3,1510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1510,1,3,0)
 ;;=3^SCREEN MAL NEOP-RESP ORG
 ;;^UTILITY(U,$J,358.3,1510,1,4,0)
 ;;=4^V76.0
 ;;^UTILITY(U,$J,358.3,1510,2)
 ;;=^295651
 ;;^UTILITY(U,$J,358.3,1511,0)
 ;;=V76.10^^21^115^26
 ;;^UTILITY(U,$J,358.3,1511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1511,1,3,0)
 ;;=3^SCREEN MAL NEOPL, BREAST,UNSP
 ;;^UTILITY(U,$J,358.3,1511,1,4,0)
 ;;=4^V76.10
 ;;^UTILITY(U,$J,358.3,1511,2)
 ;;=^317968
 ;;^UTILITY(U,$J,358.3,1512,0)
 ;;=V76.11^^21^115^27
 ;;^UTILITY(U,$J,358.3,1512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1512,1,3,0)
 ;;=3^SCREEN MAMMO HIGH-RISK PT
 ;;^UTILITY(U,$J,358.3,1512,1,4,0)
 ;;=4^V76.11
 ;;^UTILITY(U,$J,358.3,1512,2)
 ;;=^317969
 ;;^UTILITY(U,$J,358.3,1513,0)
 ;;=V76.12^^21^115^8
 ;;^UTILITY(U,$J,358.3,1513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1513,1,3,0)
 ;;=3^OTHER SCREEN MAMMO FOR MAL NEO
 ;;^UTILITY(U,$J,358.3,1513,1,4,0)
 ;;=4^V76.12
 ;;^UTILITY(U,$J,358.3,1513,2)
 ;;=^317970
 ;;^UTILITY(U,$J,358.3,1514,0)
 ;;=V76.19^^21^115^7
 ;;^UTILITY(U,$J,358.3,1514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1514,1,3,0)
 ;;=3^OTHER SCREEN BREAST EXAM
 ;;^UTILITY(U,$J,358.3,1514,1,4,0)
 ;;=4^V76.19
 ;;^UTILITY(U,$J,358.3,1514,2)
 ;;=^295652
 ;;^UTILITY(U,$J,358.3,1515,0)
 ;;=V76.2^^21^115^21
 ;;^UTILITY(U,$J,358.3,1515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1515,1,3,0)
 ;;=3^SCREEN MAL NEOP-CERVIX
 ;;^UTILITY(U,$J,358.3,1515,1,4,0)
 ;;=4^V76.2
 ;;^UTILITY(U,$J,358.3,1515,2)
 ;;=^295653
 ;;^UTILITY(U,$J,358.3,1516,0)
 ;;=V76.3^^21^115^20
 ;;^UTILITY(U,$J,358.3,1516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1516,1,3,0)
 ;;=3^SCREEN MAL NEOP-BLADDER
 ;;^UTILITY(U,$J,358.3,1516,1,4,0)
 ;;=4^V76.3
 ;;^UTILITY(U,$J,358.3,1516,2)
 ;;=^295654
 ;;^UTILITY(U,$J,358.3,1517,0)
 ;;=V76.41^^21^115^23
 ;;^UTILITY(U,$J,358.3,1517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1517,1,3,0)
 ;;=3^SCREEN MAL NEOP-RECTUM
 ;;^UTILITY(U,$J,358.3,1517,1,4,0)
 ;;=4^V76.41
 ;;^UTILITY(U,$J,358.3,1517,2)
 ;;=^295655
 ;;^UTILITY(U,$J,358.3,1518,0)
 ;;=V76.42^^21^115^22
 ;;^UTILITY(U,$J,358.3,1518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1518,1,3,0)
 ;;=3^SCREEN MAL NEOP-ORAL CAV
 ;;^UTILITY(U,$J,358.3,1518,1,4,0)
 ;;=4^V76.42
 ;;^UTILITY(U,$J,358.3,1518,2)
 ;;=^295656
 ;;^UTILITY(U,$J,358.3,1519,0)
 ;;=V76.43^^21^115^25
 ;;^UTILITY(U,$J,358.3,1519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1519,1,3,0)
 ;;=3^SCREEN MAL NEOP-SKIN
 ;;^UTILITY(U,$J,358.3,1519,1,4,0)
 ;;=4^V76.43
 ;;^UTILITY(U,$J,358.3,1519,2)
 ;;=^295657
 ;;^UTILITY(U,$J,358.3,1520,0)
 ;;=V76.44^^21^115^73
 ;;^UTILITY(U,$J,358.3,1520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1520,1,3,0)
 ;;=3^SP SCR-MALIG NEOP PROSTATE
 ;;^UTILITY(U,$J,358.3,1520,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,1520,2)
 ;;=^321548
 ;;^UTILITY(U,$J,358.3,1521,0)
 ;;=V76.45^^21^115^74
 ;;^UTILITY(U,$J,358.3,1521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1521,1,3,0)
 ;;=3^SP SCR-MALIG NEOP TESTIS
 ;;^UTILITY(U,$J,358.3,1521,1,4,0)
 ;;=4^V76.45
 ;;^UTILITY(U,$J,358.3,1521,2)
 ;;=^321549
 ;;^UTILITY(U,$J,358.3,1522,0)
 ;;=V76.46^^21^115^82
 ;;^UTILITY(U,$J,358.3,1522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1522,1,3,0)
 ;;=3^SPEC SCRN MALIG NEOPLASM,OVARY
 ;;^UTILITY(U,$J,358.3,1522,1,4,0)
 ;;=4^V76.46
 ;;^UTILITY(U,$J,358.3,1522,2)
 ;;=^322084
 ;;^UTILITY(U,$J,358.3,1523,0)
 ;;=V76.47^^21^115^81
 ;;^UTILITY(U,$J,358.3,1523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1523,1,3,0)
 ;;=3^SPEC SCRN MALIG NEOPLAS,VAGINA
 ;;^UTILITY(U,$J,358.3,1523,1,4,0)
 ;;=4^V76.47
 ;;^UTILITY(U,$J,358.3,1523,2)
 ;;=^322085
 ;;^UTILITY(U,$J,358.3,1524,0)
 ;;=V76.50^^21^115^77
 ;;^UTILITY(U,$J,358.3,1524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1524,1,3,0)
 ;;=3^SPC SCRN MALIG NEO,UNS INTESTI
 ;;^UTILITY(U,$J,358.3,1524,1,4,0)
 ;;=4^V76.50
 ;;^UTILITY(U,$J,358.3,1524,2)
 ;;=^322088
 ;;^UTILITY(U,$J,358.3,1525,0)
 ;;=V76.51^^21^115^78
 ;;^UTILITY(U,$J,358.3,1525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1525,1,3,0)
 ;;=3^SPC SCRN MALIG NEOPLASM,COLON
 ;;^UTILITY(U,$J,358.3,1525,1,4,0)
 ;;=4^V76.51
 ;;^UTILITY(U,$J,358.3,1525,2)
 ;;=^322089
 ;;^UTILITY(U,$J,358.3,1526,0)
 ;;=V76.81^^21^115^76
 ;;^UTILITY(U,$J,358.3,1526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1526,1,3,0)
 ;;=3^SPC SCRN MALIG NEO,NERV SYS
 ;;^UTILITY(U,$J,358.3,1526,1,4,0)
 ;;=4^V76.81
 ;;^UTILITY(U,$J,358.3,1526,2)
 ;;=^322091
 ;;^UTILITY(U,$J,358.3,1527,0)
 ;;=V77.0^^21^115^51
 ;;^UTILITY(U,$J,358.3,1527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1527,1,3,0)
 ;;=3^SCREEN-THYROID DISORDER
 ;;^UTILITY(U,$J,358.3,1527,1,4,0)
 ;;=4^V77.0
 ;;^UTILITY(U,$J,358.3,1527,2)
 ;;=^295661
 ;;^UTILITY(U,$J,358.3,1528,0)
 ;;=V77.1^^21^115^36
 ;;^UTILITY(U,$J,358.3,1528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1528,1,3,0)
 ;;=3^SCREEN-DIABETES MELLITUS
 ;;^UTILITY(U,$J,358.3,1528,1,4,0)
 ;;=4^V77.1
 ;;^UTILITY(U,$J,358.3,1528,2)
 ;;=^295662
